botulax

Product Details

Botulinum toxin is a neurotoxin. It acts on cholinergic motor nerve endings, antagonizes the effect of calcium ions, interferes with the release of acetylcholine from the motor nerve endings, and promotes the inability of muscle fibers to contract, thus reducing muscle tension and relieving spasms. Botulax, carefully developed by South Korea’s HUGEL company, is a botulinum toxin preparation. Since its launch in 2010, it has been approved for the treatment of blepharospasm, eyebrow wrinkles, upper limb muscle stiffness after stroke, and pointed foot deformity after polio. Multiple indications. In addition, indications for the treatment of neurogenic urinary incontinence and overactive bladder syndrome are also under application.

Compared with some botulinum toxin products on the market, Botulax product technology and process have been strictly certified by the Korean Food and Drug Administration and GMP, which is safe and reliable. A long and complete record of safety and effectiveness has enabled Botulax to gain explosive growth and praise, selling well in 27 countries and regions.